论文部分内容阅读
支气管动脉介入技术是治疗肺癌、大咯血等肺部重症疾患的重要手段,自1973年Remy首次应用以来。已经有了很大的发展,但是其脊髓损伤致截瘫等严重并发症给医患双方带来很大的精神压力。为了降低这一严重并发症的发生率,许多作者在治疗方法上作了改进,但其发生率仍在1.5%左右。笔者应用利多卡因脊髓功能诱发试验来判断支气管肋间动脉干有无合并脊髓根动脉,现报告如下: 1 资料与方法 1.1 一般资料我院从1991年2月至2000年5月进行支气管动脉介入治疗464例,其中肺癌416例。大咯血48例。从2000年 6月至2004年5月进行支气管动脉介入治疗215例,其中肺癌180例,大咯血35例,治疗方法同前,术前采用利多
Bronchial artery interventional technology is an important means of treating severe lung diseases such as lung cancer and hemoptysis, since the first application of Remy in 1973. There have been great developments, but serious complications such as paraplegia caused by spinal cord injury have brought great mental stress to both doctors and patients. In order to reduce the incidence of this serious complication, many authors have made improvements in their treatment, but their incidence is still around 1.5%. I use lidocaine spinal cord induction test to determine the presence or absence of bronchial artery trunk with spinal cord root canal, are as follows: 1 Materials and Methods 1.1 General Information Our hospital from February 1991 to May 2000 for bronchial artery intervention Treatment of 464 cases, of which 416 cases of lung cancer. 48 cases of massive hemoptysis. From June 2000 to May 2004, 215 cases of bronchial artery interventional therapy, including 180 cases of lung cancer, hemoptysis in 35 cases, the same treatment as before, preoperative Lido